09022833777
Sections
Search
Subscribe
DealCurry
Equity
Venture Capital
Private Equity
M&A

Mergers & Acquisitions | 28 April 2011

Biocon To Sell Its 78% Stake In AxiCorp For $58 Mn

by Deeshesh Chheda
Biocon To Sell Its 78% Stake In AxiCorp For $58 Mn
Share on Social Media Email Facebook Twitter Linkedin
 
@deeshesh

@Biocon_Limited1 Ltd will be selling its entire 78% stake in it's German unit, AxiCorp GmbH, to minority shareholders, for 40 million euros ($58.2 Mn).

AxiCorp was the licensee for Biocon's insulin and Glargine products in Germany and had the sole responsibility for commercialising these products.

Transactio Reference: Business Standard


Religare To Raise Rs 800 Cr Via Rights Issue

Religare To Raise Rs 800 Cr Via Rights Issue

Religare Enterprises Limited will raise Rs.800 Cr through rights issue, with an option to increase the issue size by additional 10%.

Read More...

Zoomcar Secures Funding From Sequoia Capital, Others

Zoomcar Secures Funding From Sequoia Capital, Others

Bangalore based ZoomCar India Private Limited, a self-driven car rental startup, has raised $8 Mn in new round of funding led by Sequoia Capital India. Other investors include former Infosys CFO Mohandas Pai and Manipal Group's head of corporate affairs Abhay Jain.

Read More...
DealCurry Timeline
TL Home Search New Keet
CONTACT US
Info@DealCurry.com
09022833777
A 314, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
 
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.